TRABALHOS QUE SERÃO APRESENTADOS NO DIA 23 DE MAIO. LOCAL: HALL DO PRÉDIO V
|
|
|
- Moris Strickland
- 7 years ago
- Views:
Transcription
1 TRABALHOS QUE SERÃO APRESENTADOS NO DIA 23 DE MAIO. LOCAL: HALL DO PRÉDIO V 1. ADHERENCE TO DRUG TREATMENT IN PATIENTS OF A COMMUNITY PHARMACY OF FEDERAL UNIVERSITY OF GOIÁS 2. ADVERSE REACTIONS AND QUALITY OF LIFE IN HEAD AND NECK CANCER PATIENTS TREATING WITH CISPLATIN CHEMOTHERAPY AND RADIOTHERAPY 3. ADVERSE REACTIONS IN PATIENTS WITH BREAST CANCER: A RETROSPECTIVE STUDY IN A PRIVATE CLINIC OF TERESINA PI 4. AN ALGORITHM DEVELOPMENT TO FACILITATE THE PHARMACEUTICAL CARE PRACTICE IN A PUBLIC HEALTH SYSTEM 5. ANALYSIS OF PHARMACOTHERAPEUTIC FOLLOW NEED FOR PATIENTS WITH DYSLIPIDEMIA 6. ANALYSIS OF PRESCRIPTIONS DISPENSED HEALTH UNIT IN A FAMILY JEQUIÉ, BAHIA, BRAZIL 7. ANALYSIS OF THE EVOLUTION OF THE NUMBER OF NOTIFICATIONS TO RISK MANAGEMENT SECTOR OF A SENTINEL HOSPITAL 8. ANALYSIS OF THE LIPID PROFILE OF INSTITUTIONALIZED ELDERLY 9. ANALYSIS OF THE PHARMACOVIGILANCE NOTIFICATIONS PERFORMED IN HCFMRP/USP IN ASSESSING THE PHARMACEUTICAL CARE IN BRAZIL: IDENTIFICATION OF EDUCATION SCENARIES 11. ASSESSMENT OF COGNITION IN INSTITUTIONALIZED ELDERLY 12. ASSESSMENT OF RESILIENCE IN PATIENTS WITH DEPRESSION UNDER PHARMACOTHERAPY FOLLOW-UP 13. AURICULOCUPUNTURE REDUCE WEIGHT AND ANXIETY IN OBESE AND OVERWEIGHT 14. AVALIAÇÃO DA EFETIVIDADE DA ATENÇÃO FARMACÊUTICA NO TRATAMENTO DE PACIENTES COM TRANSTORNO BIPOLAR DO HUMOR 15. AVALIATION OF ANALGESIC USE AND SELF-MEDICATION IN PHARMACY AND NURSING STUDENTS OF FEDERAL UNIVERSITY OF PARAÍBA 16. EVALUATION OF THE UTILIZATION PROFILE OF ANTIMICROBIAL DISPENSED IN A DRUGSTORE FROM MANGABEIRA, JOÃO PESSOA/PARAÍBA 17. BARRIERS TO IMPLEMENTATION OF PHARMACEUTICAL SERVICES IN FARMÁCIA POPULAR OF BRASIL, IN SERGIPE 18. BARRIERS TO MEDICATION ADHERENCE IN PATIENTS WITH POOR METABOLIC CONTROL OF TYPE 2 DIABETES 19. BIOACTIVITY OF PLANTS EXTRACTS FOUND IN BRAZIL 20. BIRTH CONTROL METHODS AND STD KNOWLEDGE EVALUATION IN YOUNG ADULTS POPULATION, DIVINÓPOLIS MG
2 BRASIL 21. CASE REPORT OF PHARMACEUTICAL CARE FOR PATIENTS IN HEMODIALYSIS 22. CHARACTERISTICS AND FACTORS ASSOCIATED WITH PHARMACIST INTERVENTIONS DURING THE DISPENSING PROCESS IN A UNIV 23. CLINICAL AND SOCIOECONOMIC PROFILE OF HEMODIALYSIS PATIENTS PARTICIPATING IN A PHARMACEUTICAL CARE CLINICAL TRIAL 24. CLINICAL ASPECTS RELEVANT TO THE PHARMACOTHERAPEUTIC FOLLOW-UP OF PARKINSON'S DISEASE PATIENTS 25. CLINICAL PHARMACIST PERFORMANCE IN MULTIPROFESSIONAL TEAM IN A TEACHING HOSPITA 26. CLINICAL, SOCIAL AND ECONOMIC IMPACT OF PHARMACEUTICAL CARE IN THE CONTROL OF HYPERTENSIVE OUTPATIENTS 27. DEPLOYMENT OF PHARMACEUTICAL ASSISTANCE AS A MEANS OF SOCIAL COMMUNICATION THROUGH PROGRAM RADIOVISÃO IN RADIO SANTO ANGELO AM (903KHZ) 28. DESCRIPTION OF PHARMACEUTICAL CARE TO ASSESS THEIR EFFECTIVENESS ON ADHERENCE TO ANTIRETROVIRAL THERAPY- A RANDOMIZED CLINICAL TRIAL 29. DISCOVERY PLACE: THE PHARMACEUTICAL CARE ON ASSISTANCE, RESEARCH AND QUALITY TEACHING. 30. DRUG AND FOOD INTERACTIONS: A FIELD FOR PHARMACEUTICAL CARE INTERVENTION 31. DRUG DISPENSING SYSTEM WITH ELECTRONIC MONITORING 32. DRUG INTERACTIONS BETWEEN HERBAL ANS CHEMOTHERAPEUTIC IN PATIENTS SERVED IN CONSULTING PHARMACIST - UNIFENAS CAMPUS VARGINHA 33. DRUG THERAPY DIFFICULTIES IN PEDIATRIC GASTROENTEROLOGY: REVIEW OF LITERATURE 34. EDUCAÇÃO CONTINUADA A DISTÂNCIA: A EXPERIÊNCIA DO SIG DE CUIDADOS FARMACÊUTICOS 35. EDUCATIVE ACTIVITIES ABOUT RATIONAL USE OF DRUGS FOR BASIC EDUCATION'S STUDENTS 36. EFFECT OF IMPLEMENTATION OF PHARMACEUTICAL SERVICES IN A COMMUNITY PHARMACY 37. EFFECT OF PACKAGE INSERTS ON PHARMACOTHERAPY ADHERENCE: A SURVEY WITH PATIENTS USING SIMVASTATIN 38. EFFECTIVENESS OF PHARMACEUTICAL CARE IN PATIENTS SUFFERING FROM DEPRESSION 39. EFFECTIVENESS OF PHARMACEUTICAL CARE IN PATIENTS WITH HYPERTENSION ASSISTED BY FAMILY HEALTH STRATEGY 40. EVALUATION OF CLINICAL AND ECONOMIC IMPACT OF PHARMACEUTICAL CARE UNDER UNIQUE HEALTH SYSTEM 41. EVALUATION OF CLINICAL AND HUMANISTIC OUTCOMES OF THE DISPENSING PROCESS PROVIDED BY PHARMACISTS IN A UNIVERSITY PHARMACY
3 42. EVALUATION OF DRUG INTERACTIONS IN USERS OF PUBLIC PHARMACIES IN DIVINÓPOLIS - MG 43. EVALUATION OF PRACTICE OF PHARMACEUTICAL DISPENSING THROUGH TECHNICAL SIMULATED PATIENT : CASE STUDY 44. EVALUATION OF THE EPIDEMIOLOGIC AND THERAPEUTIC PROFILE OF KIDNEY CHRONIC PATIENTS ASSISTED BY SUS IN TERESINA - PIAUI 45. EVALUATION OF UNLICENSED AND OFF-LABEL ANTIEPILEPTIC DRUGS PRESCRIBED TO CHILDREN: BRAZILIAN REGULATORY AGENCY VERSUS FDA 46. FREQUENCY OF ADVERSE EFFECTS CAUSED BY AMINOGLYCOSIDES 47. HOSPITAL ADMISSION OF ONCOLOGY PATIENTS FOR NAUSEA AND VOMITING INDUCED BY ANTINEOPLASTIC CHEMOTHERAPY 48. HOW ANTIMICROBIALS CONTROLLED SALE INFLUENCE BACTERIAL RESISTANCE IN BRAZIL? 49. IMPLEMENTATION OF A CLINICAL PHARMACY SERVICE AND ANALYSIS OF THE PHARMACOTHERAPEUTIC INTERVENTIONS IN THE NEUROLOGY SECTOR OF HCFMRP/USP 50. IMPLEMENTATION OF CLINICAL PHARMACY SERVICE FOR PREVENTING MEDICATION ERRORS IN INTENSIVE CARE UNIT OF WOMEN S PUBLIC HEALTH
4 TRABALHOS QUE SERÃO APRESENTADOS NO DIA 24 DE MAIO. LOCAL: HALL DO PRÉDIO V 51. DISTRIBUTION ESTRATEGY OF THE MISOPROSTOL IN THE STATE OF MINAS GERAIS 52. IMPLEMENTATION OF PHARMACOTHERAPY REVIEW AS STRATEGY FOR PATIENT CARE: PILOT STUDY 53. IMPROVEMENT OF VARIOUS SYMPTOMS AFTER A AURICULOACUPUNCTURE SESSION 54. INDICATORS OF DIABETIC PATIENTS FOR PHARMACEUTICAL ATTENTION USERS OF INSULIN 55. KNOWLEDGE AND PRACTICES OF LIVING WITH HIV / AIDS IN RESIDENTS OF LONG-STAY SHELTERS IN ANTIRETROVIRAL THERAPY 56. KNOWLEDGE OF PATIENTS ON DRUGS PRESCRIBED IN OUTPATIENT CLINICS OF A UNIVERSITY HOSPITAL IN NORTHEAST BRAZIL 57. LEVEL OF INFORMATION ABOUT THE DISEASE AND THE TREATMENT: AN OVERVIEW OF A GROUP OF BREAST CANCER PATIENTS IN PHARMACOTHERAPEUTIC FOLLOW-UP 58. LOW SENSITIVITY AND MORISKY TEST SPECIFICITY FOR ASSESSMENT OF PATIENTS COMPLIANCE TO THE TREATMENT OF ANTIRETROVIRAL HIV/SIDA 59. MAJOR DRUG INTERACTIONS WITH ANTIBIOTICS 60. MEDICATION ADHERENCE: A CALL FOR PHARMACEUTICAL ORIENTATION 61. MEDICATION ERRORS IN COMMUNITY PHARMACIES 62. MEDICATION RECONCILIATION: A PROSPECTIVE STUDY IN ADULT PATIENTS 63. MEDICINAL PLANTS COMMERCIALIZED IN PUBLIC MARKETS OF JOÃO PESSOA AND THEIR INTERACTION WITH SYNTHETIC DRUGS OF PHARMACOLOGICAL CLASSES 64. MONITORING OF CISPLATIN EXCRETION AND ITS RELATION WITH ADVERSE REACTIONS IN HEAD AND NECK CANCER PATIENTS 65. NAFAU NÚCLEO DE ATENÇÃO FARMACÊUTICA DA UNIFAL MG: ONE-YEAR EXPERIENCE 66. OBJECTIVE STRUCTRUTED CLINICAL EXAMINATIONS (OSCE): NA EXPERIENCE IN THE ASSESSMENT OF STUDENTS IN THE DISCIPLINE OF PHARMACEUTICAL SEMIOLOGY 67. PATIENT SATISFACTION WITH THE PHARMACEUTICAL SERVICES RENDERED BY THREE COMMUNITY PHARMACIES IN THE STATE OF SERGIPE 68. PATIENT-RELATED NEEDS: AN IMPORTANT INDICATOR FOR PHARMACEUTICAL CARE 69. PERSONAL FACTORS THAT CONTRIBUTE TO NO ADHERENCE TO ANTIRETROVIRAL THERAPY - EVALUATION OF SELF-
5 EFFICACY EXPECTATION 70. PHARMACEUTICAL CARE FOR DEPRESSION PATIENTS USING TELEMEDICINE STRATEGY 71. PHARMACEUTICAL CARE FOR PATIENTS ENROLLED IN THE HIPERDIA PROGRAM ATTENDED IN THE FHS/CAIC IN MACHADO-MG. 72. PHARMACEUTICAL CARE FOR PATIENTS WITH HYPERTENSION IN FAMILY HEALTH STRATEGY OF GOIÂNIA-GO 73. PHARMACEUTICAL CARE IN HYPERTENSIVE PATIENTS: A PILOT STUDY 74. PHARMACEUTICAL CARE IN PATIENT WITH SHORT BOWEL SYNDROME: A CASE REPORT 75. PHARMACEUTICAL CARE INTERVENTION (PCI) TO AN ELDERLY PATIENT WITH UNCONTROLLED METABOLIC SYNDROME: A CASE REPORT 76. PHARMACEUTICAL CARE TO ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE PATIENTS 77. PHARMACEUTICAL CARE TO ELDERLY PATIENTS FROM A LONG PERMANENCE INSTITUTE 78. PHARMACEUTICAL CARE TO PROMOTE SELF-CARE AND IMPROVING QUALITY OF LIFE IN HEMODIALYSIS PATIENTS 79. PHARMACEUTICAL CARE TO SICKLE CELL ANEMIA PATIENTS: A PILOT STUDY 80. PHARMACEUTICAL INTERVENTION IN PHARMACOTHERAPY 81. PHARMACEUTICAL ORIENTATION AT THE TIME OF HOSPITAL DISCHARGE: STRENGTHENING ADHERENCE AND PROVIDING CONTINUITY OF CARE 82. PHARMACOTHERAPEUTIC FOLLOW UP SERVICE PROTOCOL IN DYSLIPIDEMIA 83. PHARMACOTHERAPEUTIC FOLLOW-UP IN HEAD AND NECK CANCER 84. PHARMACOTHERAPEUTIC MONITORING IN PHARMACIST OFFICE SCHOOL CAMPUS UNIFENAS VARGINHA 85. PHARMACOTHERAPY REVIEW: A STRATEGY OF HEALTH CARE PROVISION DURING PHARMACOTHERAPEUTIC FOLLOW- UP 86. PHARMACOVIGILANCE IN ONCOLOGY: MONITORING THE ADVERSE DRUG REACTION OF ANTINEOPLASIC TREATMENT AND SEVERITY DEGREES 87. PLAN OF PHARMACEUTICAL CARE IN DIABETIC PATIENTS ON HEMODIALYSIS - DIETARY AND MEDICAMENTOUS INTERVENTIONS - CASE REPORT 88. POTENTIAL DRUG INTERACTIONS IN INTENSIVE CARE UNITS 89. PREDICTORS OF NON-ADHERENCE TO CLINICAL FOLLOW-UP AMONG PATIENTS PARTICIPATING IN A RANDOMIZED TRIAL TESTING A PHARMACEUTICAL CARE INTERVENTION IN HIV-POSITIVE ADULTS IN SOUTHERN BRAZIL 90. RAIZEIROS: THE UNIVERSE OF FOLK MEDICINE PROFESSIONALS AND THEIR ROLE IN THE HEALTH/DISEASE PROCESS
6 OF POPULATION FROM JOÃO PESSOA 91. RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE IMPACT OF PHARMACEUTICAL CARE ON THERAPEUTIC SUCCESS IN HIV-INFECTED PATIENTS IN SOUTHERN BRAZIL 92. RATIONAL USE OF ANTIMICROBIALS: NA ANALYSIS OF THE PROFILE OF PRESCRIPTIONS FROM "HOSPITAL UNIVERSITÁRIO LAURO WANDERLEY" PEDIATRIC INFIRMARY 93. RATIONAL USE OF DRUGS: EDUCATION FOR COMMUNITY HEALTH AGENTS 94. RESULTS OF MEDICATION THERAPY MANAGEMENT IMPLANTATION 95. SAFETY IN PREGNANT AND PUERPERAL PATIENTS IN INTENSIVE CARE UNIT 96. SECURITY PROBLEM CYCLOSPORINE: SUSPECTED ADVERSE REACTION - HEPATOTOXCITY 97. THE IMPORTANCE OF THE IMPLEMENTATION OF PHARMACEUTICAL CARE IN A HOME CARE IN FORTALEZA-CE 98. THE OBJECTIVE STRUCTURED CLINICAL EXAMINATION AS A NEW STRATEGY FOR TEACHING AND LEARNING IN THE DISCIPLINE OF PHARMACEUTICAL CARE 99. TRANSLATION AND CROSS-CULTURAL ADAPTATION OF SUBTITLES OF THE UNITED STATES PHARMACOPEIA - DISPENSING INFORMATION (USP-DI) FOR GUIDANCE TO ELDERLY IN ARACAJU (SE) ABOUT USING DRUGS 100. USE IN PREGNANCY DRUG ATTENDED BY A TEAM OF HEALTH PROGRAM FAMILY 101. UTILIZATION AND KNOWLEDGE ABOUT GENERIC DRUGS IN SOUTHERN BRAZIL - POPULATION-BASED STUDY 102. WRITTEN INFORMATION GIVEN TO PATIENTSOF COUMPOUNDED DRUGS USERS: LITERATURE REVIEW
REGULATIONS FOR THE DEGREE OF MASTER OF CLINICAL PHARMACY (MClinPharm)
REGULATIONS FOR THE DEGREE OF MASTER OF CLINICAL PHARMACY (MClinPharm) (See also General Regulations) MCP1 Definition The degree of Master of Clinical Pharmacy (MClinPharm) is a postgraduate degree awarded
Addressing forecasted oncologist shortage: A Cancer Education Program for Pharmacy Students (CEPPS)
Addressing forecasted oncologist shortage: A Cancer Education Program for Pharmacy Students (CEPPS) Dr. Department of Pharmacy Practice State University of New York School of Pharmacy and Pharmaceutical
Requirements for Drug Information Centres
FIP Pharmacy Information Section Requirements for Drug Information Centres Summary All countries should provide drug information services either independently or as part of a regional network. The service
Definition of Investigational Medicinal Products (IMPs) Definition of Non Investigational Medicinal Products (NIMPs)
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Definition of Investigational Medicinal Products (IMPs) Definition of Non Investigational Medicinal Products
10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary
Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron
Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge
Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages
BAPTIST MEDICAL CENTER JACKSONVILLE
BAPTIST MEDICAL CENTER JACKSONVILLE Baptist Medical Center Jacksonville, a 444-bed tertiary hospital that is the flagship of Baptist Health in Jacksonville, Florida, is centrally located on the south bank
Algorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification
Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare
Monash University - Master of Clinical Pharmacy
Monash University - Master of Clinical The Master of Clinical is a 48 credit point program, equivalent to one year of full time study (generally completed in 2 years part time). It comprises 1200 hours
A pharmacist s guide to Pharmacy Services compensation
Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription
UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM
BOARD OF PHARMACY SPECIALTIES PHARMACOTHERAPY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2015/FOR USE ON FALL 2016 EXAMINATION AND FORWARD UNDERSTANDING THE CONTENT
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Medication Adherence Services
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Introduction Medication adherence can be generally defined as the extent to which a patient takes medication as prescribed by his
Incidence of drug related problems
Incidence of drug related problems Birthe Søndergaard Associate Professor. Faculty of Pharmaceutical Sciences. University of Copenhagen Disposition Drug related problems definition and classifications
PHARMACOVIGILANCE GUIDELINES
PHARMACOVIGILANCE GUIDELINES What is Pharmacovigilance? Pharmacovigilance is defined as the science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions
Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program
Basic Ingredients of the CHCC PGY-1 Pediatric Pharmacy Residency Program Pediatric Pharmacy Residency Program (PGY1) Children s Hospital Central California offers a one-year, postgraduate residency program
Course Curriculum for Master Degree in Clinical Pharmacy
Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon
Risk Management Plan (RMP) on Biologicals and NCE
Transformation towards a New Regulatory Paradigm Risk Management Plan (RMP) on Biologicals and NCE Junko SATO International Coordination Officer PMDA, Japan 1 2 Pharmaceuticals and Medical Devices Agency
Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER
Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LT Andrew Fine, Pharm.D., BCPS Safety Evaluator Division of Pharmacovigilance Office of Pharmacovigilance and Epidemiology
Risk Management Plan (RMP) Guidance (Draft)
Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour
Medical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management
G.2 At a Glance G.3 Procedures Requiring Prior Authorization G.5 How to Contact or Notify Medical Management G.6 When to Notify Medical Management G.9 Case Management Services G.12 Special Needs Services
THE FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES COURSE PLAN CLINICAL CLERKSHIP
THE FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES COURSE PLAN CLINICAL CLERKSHIP **The cardinal rule of rotations is THE MORE INTEREST YOU SHOW IN LEARNING,
How Can We Get the Best Medication History?
How Can We Get the Best Medication History? Stephen Shalansky, Pharm.D., FCSHP Pharmacy Department, St. Paul s Hospital Faculty of Pharmaceutical Sciences, UBC How Are We Doing Now? Completeness of Medication
PGY-1 General Pharmacy Practice Residency (Inpatient & Outpatient)
(Inpatient & Outpatient) PGY-1 pharmacy residency programs at the William S. Middleton Veterans Hospital (also known as the Madison VA ) have been in existence for 30 years and Art Schuna has trained over
Pharmacist independent prescribing programme learning outcomes and indicative content
Pharmacist independent prescribing programme learning outcomes and indicative content Learning outcomes All providers of GPhC accredited independent prescribing programmes need to ensure that following
IN-NETWORK MEMBER PAYS. Out-of-Pocket Maximum (Includes a combination of deductible, copayments and coinsurance for health and pharmacy services)
HMO-OA-CNT-30-45-500-500D-13 HMO Open Access Contract Year Plan Benefit Summary This is a brief summary of benefits. Refer to your Membership Agreement for complete details on benefits, conditions, limitations
Guidance on competencies for management of Cancer Pain in adults
Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine
Clinical pathway concept - a key to seamless care
SECTION 5: PATIENT SAFETY AND QUALITY ASSURANCE 1 Clinical pathway concept - a key to seamless care Audrey Janoly-Dumenil, Hôpital Edouard Herriot, CHU Lyon Marie-Camille Chaumais, Hôpital Antoine Béclère,
Intervention Databases: A Tool for Documenting Student Learning and Clinical Value. Program Overview. Background
Intervention Databases: A Tool for Documenting Student Learning and Clinical Value Debra Copeland, B.S., Pharm.D., R.Ph. Margarita DiVall, Pharm.D., BCPS Ruth Nemire, B.S.Ph., Pharm.D. Beverly Talluto,
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
Institute for Safe Medication Practices
Institute for Safe Medication Practices 1800 Byberry Road, Suite 810 Huntingdon Valley, PA 19006 FOR MORE INFORMATION, CONTACT : Michael A. Donio, MPA Marketing & Consumer Affairs 215-947-7797 Mdonio@ismp.org
Original Policy Date
MP 5.01.20 Tysabri (natalizumab) Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Local Policy/12:2013 Return to Medical Policy Index Disclaimer
MEDICATION THERAPY ADHERENCE CLINIC : DIABETES
MEDICATION THERAPY ADHERENCE CLINIC : DIABETES PHARMACEUTICAL SERVICES DIVISION MINISTRY OF HEALTH MALAYSIA First Edition, 2010 Pharmaceutical Services Division Ministry of Health, Malaysia ALL RIGHT RESERVED
Concept Series Paper on Disease Management
Concept Series Paper on Disease Management Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing
CTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse
Formulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
Continuing education for community pharmacists in Denmark the case of Master of Drug Management
Continuing education for community pharmacists in Denmark the case of Master of Drug Management Birthe Søndergaard Associate Professor Department of Pharmacology and Pharmacotherapy, Section of Social
Developing Pharmacist-Managed Clinics in the Outpatient Setting
Developing Pharmacist-Managed Clinics in the Outpatient Setting Name : R Mohd Khairul Anuar R Ismail Unit : Drug Information Unit Preceptor : Pn Zalina Zahari A Primer for Developing Pharmacist- Managed
PGY-2 ONCOLOGY PHARMACY RESIDENCY
PGY-2 ONCOLOGY PHARMACY RESIDENCY Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health system including
Michigan Department of Licensing and Regulatory Affairs Pain and Symptom Management Speakers Bureau
Michigan Department of Licensing and Regulatory Affairs Pain and Symptom Management Speakers Bureau Are you looking for a speaker to present at your conference, ground rounds, or brown bag lunch? If you
Learn More About Product Labeling
Learn More About Product Labeling Product label The product label is developed during the formal process of review and approval by regulatory agencies of any medicine or medical product. There are specific
Understanding Our Curriculum
Understanding Our Curriculum One question that comes up quiet frequently when talking with preceptors is what are we teaching our students and when are they exposed to certain classes. Below you will find
Master's Clinical Pharmacy (Thesis Track)
Master's Clinical Pharmacy (Thesis Track) I. GENERAL RULES CONDITIONS: Plan Number 3 \ 12 06 2010 T 1. This plan conforms to the valid regulations of the programs of graduate studies. 2. Areas of specialty
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company PRESCRIPTION DRUG RIDER This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health
Guidance notes. for Patient Safety and Pharmacovigilance in Patient Support Programmes
Guidance notes for Patient Safety and Pharmacovigilance in Patient Support Programmes 9 May 2011 Approval Status Authors The ABPI Pharmacovigilance Expert Network Change History N/A Approval Date 9 May
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07
Member name, address, phone number, DOB, MC400 Member ID, MA Recipient Number
CONNECTED CARE DATA TEMPLATE Member Tier Display SMI Tier 1, 2, or 3 (plus historical activity to show changes in tier) Member Demographics Member name, address, phone number, DOB, MC400 Member ID, MA
Maryland Cancer Plan Pain Management Committee
Maryland Cancer Plan Pain Management Committee IDEAL MODEL FOR CANCER CONTROL PROBLEM or ISSUE Lack of provider awareness regarding appropriate pain assessment and management and relevant policy Definition:
Barriers to Effective Pain Management. Dr. Huda Abu-Saad Huijer Director Hariri School of Nursing
Barriers to Effective Pain Management Dr. Huda Abu-Saad Huijer Director Hariri School of Nursing Introduction Unrelieved pain is a major, yet avoidable, public health problem. Despite more than 30 years
EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston
Erin-Marie Beals Phone 1-781-681-2850 September 9, 2014 EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston Data include
Pharmacy and Therapeutics Committee Policies and Procedures
Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed
Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
Glossary of Clinical Trial Terms
Glossary of Clinical Trial Terms ADVERSE REACTION: (Adverse Event): Also known as side effects, adverse reactions include any undesired actions or effects of the experimental drug or treatment. Experimental
Outpatient/Ambulatory Health Services
Outpatient/Ambulatory Health Services Service Definition Outpatient/ambulatory medical care includes the provision of professional diagnostic and therapeutic services rendered by a physician, physician
MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)
MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are
Ryan White Program Services Definitions
Ryan White Program Services Definitions CORE SERVICES Service categories: a. Outpatient/Ambulatory medical care (health services) is the provision of professional diagnostic and therapeutic services rendered
Understanding Alberta s Drug Schedules
Understanding Alberta s Drug Schedules Preface In May 2002, the provincial drug schedules to the Pharmaceutical Profession Act were amended. In April 2007, the Alberta Regulation 66/2007 to the Pharmacy
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 bps@aphanet.org www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 bps@aphanet.org www.bpsweb.org Content Outline for the PSYCHIATRIC PHARMACY SPECIALTY
National Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
Not All Clinical Trials Are Created Equal Understanding the Different Phases
Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact
GUIDELINES FOR PROVIDING CONSULTANT AND DISPENSING SERVICES TO ASSISTED LIVING RESIDENTS
GUIDELINES GUIDELINES FOR PROVIDING CONSULTANT AND DISPENSING SERVICES TO ASSISTED LIVING RESIDENTS A common reason for admission into assisted living facilities is to receive assistance with medication
COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES
Rule 950 3 CCR 713-37 COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES Basis: The authority for the promulgation of these
NURSING RESEARCH IMPORTANT POINTS COMPONENTS COMPONENTS. Proposed timeline Consent/ protection of human
NURSING RESEARCH Implementation of a Chemotherapy-Induced Nausea and Vomiting Clinical Pathway for Moderate-high to Highly Emetogenic Chemotherapies A Nursing Research Project 2/01/2014 3/31/2015 PURPOSE:
AUBAGIO Conversation Starter
AUBAGIO Conversation Starter When you are choosing a multiple sclerosis (MS) treatment for the first time or are considering switching your MS therapy, there can be a lot to think about for both you and
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among
Pharmacist Support For Antiretroviral Adherence
Pharmacist Support For Antiretroviral Adherence Jennifer Cocohoba, Pharm.D.,MAS, AAHIVP Associate Clinical Professor University of California San Francisco School of Pharmacy Clinical Pharmacist, UCSF
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services Providing a wide range of clinical research services Abt Associates Clinical Trials (AACT) is dedicated to providing
Doctor of Pharmacy/Master of Public Health Joint Degree Program
Rationale Doctor of Pharmacy/Master of Public Health Joint Degree Program The Master of Public Health (MPH) program is designed to prepare students to become effective leaders, practitioners, researchers,
Introduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions
Introduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions Vision Medication Management Systems, Inc. (MMS) envisions a health care system in which all patients
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules
MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules Read this Medication Guide before your treatment. What is the most important information I should know about JUXTAPID? JUXTAPID is available
The Nurse Practitioner in HIV Care. Laura Vicol MN, NP(F) Monica Gregory MScN, NP(F)
The Nurse Practitioner in HIV Care Laura Vicol MN, NP(F) Monica Gregory MScN, NP(F) NURSE PRACTITIONERS First. Who Are we? Nurse Practitioners A New Health Care Provider in the Province of British Columbia
University of Louisville Hospital PGY1 Pharmacy Residency Program Summary
University of Louisville Hospital PGY1 Pharmacy Residency Program Summary Positions Available: 4 positions, 12 month contract Application Deadline: Early January (see PhORCAS) Requirements: On-site Interview,
The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
8/14/2012 California Dual Demonstration DRAFT Quality Metrics
Stakeholder feedback is requested on the following: 1) metrics 69 through 94; and 2) withhold measures for years 1, 2, and 3. Steward/ 1 Antidepressant medication management Percentage of members 18 years
The Evolving Role of Nurses in Early Phase Research
U.S. Department of Health and Human Services The Evolving Role of Nurses in Early Phase Research Clare Hastings, RN, PhD, FAAN Chief Nurse Officer, Clinical Center April 27, 2012 Discover America s Research
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges
Key Components of HIV Medical Case Management:
Key Components of HIV Medical Case Management: Treatment Adherence Prevention with Positives Updated 11/28/12 1 Treatment Adherence Counseling Every goal on the care plan must relate to HIV treatment/care.
Arthritis Foundation Position Statement on Biosimilar Substitution
Arthritis Foundation Position Statement on Biosimilar Substitution The Affordable Care Act creates a regulatory pathway for the approval of a new generation of biologic medications called biosimilars.
College of Pharmacy. Pharmacy Practice and Science
520 SPECIAL TOPICS IN PHARMACY LAW. (2) Discussion of the legal framework and special legal issues in pharmacy practice. Topics will include application of antitrust laws to pharmacy, patent and trademark
Outpatient Prescription Drug Benefit
Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage
FEDERAL PAIN PORTFOLIO PREVIEW
FEDERAL PAIN PORTFOLIO PREVIEW Federal Agencies: AHRQ, CDC, DoD, FDA, NIH, VA Interagency Pain Research Coordinating Committee March 27, 2012 IPRCC Charge I. Develop a summary of advances in pain care
Specialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
03/20/12. Recognize the right of patients to appropriate assessment and management of pain
Narcotic Bowel Syndrome Alvin Zfass M.D. M.D. Professor of Medicine Toufic Kachaamy M.D. GI Fellow Chronic Pain 110 million Americans suffer from chronic pain according to the NIH Cost of untreated t or
Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
LEARN MORE AT: www.aroc.org. AROC puts DO Physicians within your reach!
MARKETING GUIDE LEARN MORE AT: AROC puts DO Physicians within your reach! AROC is hosted annually by the New Jersey Association of Osteopathic Physicians and Surgeons (NJAOPS). Founded in 1901, NJAOPS
Guidance on adverse drug reactions
Guidance on adverse drug reactions Classification of adverse drug reactions Adverse drug reactions are frequently classified as type A and type B reactions. An extended version of this classification system
Medical Matters Action Checklists
Medical Matters Action Checklists The following Action Checklists are included in Chapter 5: Medical History Personal Medication Record Health Care Power of Attorney Medical Orders (Do Not Resuscitate/POLST)
PG Certificate / PG Diploma / MSc in Clinical Pharmacy
PG Certificate / PG Diploma / MSc in Clinical Pharmacy Programme Information September 2014 Entry School of Pharmacy Queen s University Belfast Queen s University Belfast - Clinical Pharmacy programme
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
MISSISSIPPI LEGISLATURE REGULAR SESSION 2016
MISSISSIPPI LEGISLATURE REGULAR SESSION 2016 By: Representative Mims To: Public Health and Human Services HOUSE BILL NO. 1187 1 AN ACT TO AMEND SECTION 73-25-34, MISSISSIPPI CODE OF 1972, 2 TO REVISE THE
SPECIALTY CASE MANAGEMENT
SPECIALTY CASE MANAGEMENT Our Specialty Case Management programs boost ROI and empower members to make informed decisions and work with their physicians to better manage their health. KEPRO is Effectively
DEPARTMENT OF REGULATORY AGENCIES. Division of Registrations
DEPARTMENT OF REGULATORY AGENCIES Division of Registrations 3 CCR 716-1 CHAPTER XV RULES AND REGULATIONS FOR PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES BASIS: The authority for the promulgation
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE May 11, 2015 SUBJECT EFFECTIVE DATE May 18, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Multiple Sclerosis Agents Pharmacy Service Leesa M. Allen, Deputy Secretary
Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING
Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING 09-00: PATIENT COUNSELING 09-00-0001--PATIENT INFORMATION, DRUG USE EVALUATION, AND PATIENT COUNSELING The intent of this regulation